264 related articles for article (PubMed ID: 26471004)
1. Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies.
Chan KF; Shahreel W; Wan C; Teo G; Hayati N; Tay SJ; Tong WH; Yang Y; Rudd PM; Zhang P; Song Z
Biotechnol J; 2016 Mar; 11(3):399-414. PubMed ID: 26471004
[TBL] [Abstract][Full Text] [Related]
2. Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant.
Zhang P; Haryadi R; Chan KF; Teo G; Goh J; Pereira NA; Feng H; Song Z
Glycobiology; 2012 Jul; 22(7):897-911. PubMed ID: 22492235
[TBL] [Abstract][Full Text] [Related]
3. CHO-gmt5, a novel CHO glycosylation mutant for producing afucosylated and asialylated recombinant antibodies.
Haryadi R; Zhang P; Chan KF; Song Z
Bioengineered; 2013; 4(2):90-4. PubMed ID: 22989990
[TBL] [Abstract][Full Text] [Related]
4. FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product quality.
Louie S; Haley B; Marshall B; Heidersbach A; Yim M; Brozynski M; Tang D; Lam C; Petryniak B; Shaw D; Shim J; Miller A; Lowe JB; Snedecor B; Misaghi S
Biotechnol Bioeng; 2017 Mar; 114(3):632-644. PubMed ID: 27666939
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose.
Jansing J; Sack M; Augustine SM; Fischer R; Bortesi L
Plant Biotechnol J; 2019 Feb; 17(2):350-361. PubMed ID: 29969180
[TBL] [Abstract][Full Text] [Related]
7. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.
Niwa R; Natsume A; Uehara A; Wakitani M; Iida S; Uchida K; Satoh M; Shitara K
J Immunol Methods; 2005 Nov; 306(1-2):151-60. PubMed ID: 16219319
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies.
Malphettes L; Freyvert Y; Chang J; Liu PQ; Chan E; Miller JC; Zhou Z; Nguyen T; Tsai C; Snowden AW; Collingwood TN; Gregory PD; Cost GJ
Biotechnol Bioeng; 2010 Aug; 106(5):774-83. PubMed ID: 20564614
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
10. Generation of FX
Liu W; Padmashali R; Monzon OQ; Lundberg D; Jin S; Dwyer B; Lee YJ; Korde A; Park S; Pan C; Zhang B
Biotechnol Prog; 2021 Jan; 37(1):e3061. PubMed ID: 32748555
[TBL] [Abstract][Full Text] [Related]
11. Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity.
Yamane-Ohnuki N; Kinoshita S; Inoue-Urakubo M; Kusunoki M; Iida S; Nakano R; Wakitani M; Niwa R; Sakurada M; Uchida K; Shitara K; Satoh M
Biotechnol Bioeng; 2004 Sep; 87(5):614-22. PubMed ID: 15352059
[TBL] [Abstract][Full Text] [Related]
12. Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells.
Lu L; Hou X; Shi S; Körner C; Stanley P
J Biol Chem; 2010 Nov; 285(46):36245-54. PubMed ID: 20837470
[TBL] [Abstract][Full Text] [Related]
13. In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2.
Lu L; Varshney S; Yuan Y; Wei HX; Tanwar A; Sundaram S; Nauman M; Haltiwanger RS; Stanley P
J Biol Chem; 2023 Dec; 299(12):105406. PubMed ID: 38270391
[TBL] [Abstract][Full Text] [Related]
14. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.
Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
J Immunol Methods; 2005 Nov; 306(1-2):93-103. PubMed ID: 16236307
[TBL] [Abstract][Full Text] [Related]
15. Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells.
Omasa T; Tanaka R; Doi T; Ando M; Kitamoto Y; Honda K; Kishimoto M; Ohtake H
J Biosci Bioeng; 2008 Aug; 106(2):168-73. PubMed ID: 18804060
[TBL] [Abstract][Full Text] [Related]
16. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Aliyu L; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2024; 2810():249-271. PubMed ID: 38926284
[TBL] [Abstract][Full Text] [Related]
17. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity.
Shields RL; Lai J; Keck R; O'Connell LY; Hong K; Meng YG; Weikert SH; Presta LG
J Biol Chem; 2002 Jul; 277(30):26733-40. PubMed ID: 11986321
[TBL] [Abstract][Full Text] [Related]
18. Production of non-fucosylated antibodies by co-expression of heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase.
von Horsten HH; Ogorek C; Blanchard V; Demmler C; Giese C; Winkler K; Kaup M; Berger M; Jordan I; Sandig V
Glycobiology; 2010 Dec; 20(12):1607-18. PubMed ID: 20639190
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Fc-dependent cellular cytotoxicity of Fc fusion proteins derived from TNF receptor II and LFA-3 by fucose removal from Asn-linked oligosaccharides.
Shoji-Hosaka E; Kobayashi Y; Wakitani M; Uchida K; Niwa R; Nakamura K; Shitara K
J Biochem; 2006 Dec; 140(6):777-83. PubMed ID: 17038352
[TBL] [Abstract][Full Text] [Related]
20. Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC.
Imai-Nishiya H; Mori K; Inoue M; Wakitani M; Iida S; Shitara K; Satoh M
BMC Biotechnol; 2007 Nov; 7():84. PubMed ID: 18047682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
